Analysis of Romanian Bacteroides isolates for antibiotic resistance levels and the corresponding antibiotic resistance genes

被引:16
作者
Szekely, Edit [1 ,2 ]
Eitel, Zsuzsa [3 ]
Molnar, Szabolcs [1 ]
Szasz, Izabella Eva [1 ]
Bilca, Doina [1 ]
Soki, Jozsef [3 ]
机构
[1] Emergency Cty Clin Hosp, Diagnost Lab, Targu Mures 540139, Romania
[2] Univ Med & Pharm Targu Mures, Fac Med, Dept Microbiol, Targu Mures 540139, Romania
[3] Univ Szeged, Fac Med, Inst Clin Microbiol, H-6726 Szeged, Hungary
关键词
Antibiotic susceptibility; Antibiotic resistance genes; Bacteroides; ANTIMICROBIAL SUSCEPTIBILITY; FRAGILIS GROUP; ANAEROBIC-BACTERIA; MOLECULAR ANALYSIS; EUROPE; METRONIDAZOLE; MECHANISMS; MUTATIONS; MUTANTS; STRAINS;
D O I
10.1016/j.anaerobe.2014.09.001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
As part of an ESCMID Study Group on Anaerobic Infections (ESGAI) project, a study was conducted to measure the antibiotic susceptibilities and corresponding gene contents of 53 Bacteroides fragilis group strains isolated in Romania. The antibiotic resistance data was comparable with the data found for other East-European countries. Here, no resistant isolate was found for imipenem, metronidazole and tigecycline. An increasing role of the cepA, cfxA and cfiA genes was observed in their corresponding antibiotic resistances. Moreover, no isolate was found that harbored the cfiA gene with a possible activating IS element. Clindamycin resistance was low, similarly to that the rate for the ermF gene. However, we did find some isolates with nimB, ermB, msrSA, linA, satG, tetX, tetM and bexA genes. This study was the first to provide antibiotic resistance data for clinical Bacteroides strains from Romania. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:11 / 14
页数:4
相关论文
共 15 条
  • [1] Roles of gyrA mutations in resistance of clinical isolates and in vitro mutants of Bacteroides fragilis to the new fluoroquinolone trovafloxacin
    Bachoual, R
    Dubreuil, L
    Soussy, CJ
    Tankovic, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) : 1842 - 1845
  • [2] Citron DMP IR, 2007, MANUAL CLIN MICROBIO, P911
  • [3] Cordero-Laurent E, 2012, REV ESP QUIM, V25, P261
  • [4] Eitel Z, 2013, ANAEROBE, V21, P43
  • [5] Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe
    Hedberg, M
    Nord, CE
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (06) : 475 - 488
  • [6] Prevalence of Antimicrobial Resistance among Clinical Isolates of Bacteroides fragilis Group in Canada in 2010-2011: CANWARD Surveillance Study
    Karlowsky, James A.
    Walkty, Andrew J.
    Adam, Heather J.
    Baxter, Melanie R.
    Hoban, Daryl J.
    Zhanel, George G.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (03) : 1247 - 1252
  • [7] Antimicrobial susceptibility of anaerobic bacteria in Bulgaria
    Marina, M.
    Ivanova, M.
    Kantardjiev, T.
    [J]. ANAEROBE, 2009, 15 (04) : 127 - 132
  • [8] Molina J, 2014, MIROB DRUG RESI 0307
  • [9] Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience
    Nagy, E.
    Urban, E.
    Nord, Carl Erik
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (03) : 371 - 379
  • [10] Role of topoisomerase mutations and efflux in fluoroquinolone resistance of Bacteroides fragilis clinical isolates and laboratory mutants
    Ricci, V
    Peterson, ML
    Rotschafer, JC
    Wexler, H
    Piddock, LJV
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) : 1344 - 1346